EP3383920
Æxlis-sértæk hleðsludreifing og ónæmisvirkjun með því að nota mennskt mótefni sem miðar á mjög sértækan æxlis-frumuyfirborðs-mótefnavaka
:
EP einkaleyfi í gildi á Íslandi:
29.11.2016:
10.1.2024:
16871367.5
:
8.4.2024:
15.5.2024
:
28.11.2036:
28.11.2025:
30.11.2025
:
TUMOR-SPECIFIC PAYLOAD DELIVERY AND IMMUNE ACTIVATION USING A HUMAN ANTIBODY TARGETING A HIGHLY SPECIFIC TUMOR CELL SURFACE ANTIGEN
29.11.2016
10.1.2024
8.4.2024
15.5.2024
28.11.2025
:
The Regents of the University of California:
1111 Franklin Street, 12th Floor, Oakland, CA 94607-5200, US
:
LIU, Bin:
San Francisco, California 94127, US
:
BIDLINGMAIER, Scott:
San Francisco, California 94123, US
:
SU, Yang:
South San Francisco, California 94080, US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201562261112 P:
30.11.2015:
US
:
US2016064033:
29.11.2016
:
C07K 16/40, C07K 14/725, C12N 5/0783, A61K 35/17, A61K 35/00, C07K 16/28, C12N 9/16, G01N 33/574, A61K 39/00, A61K 47/68, A61P 35/00
: 9
: 31.10.2024
: 28.11.2025
: Árnason Faktor ehf.